Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1996 Jun;40(6):1569–1571. doi: 10.1128/aac.40.6.1569

Zidovudine does not affect transplacental transfer or systemic clearance of stavudine (2',3'-didehydro-3'-deoxythymidine) in the pigtailed macaque (Macaca nemestrina).

A Odinecs 1, C Nosbisch 1, J D Unadkat 1
PMCID: PMC163373  PMID: 8726043

Abstract

Stavudine (22 micrograms/min/kg of body weight) was infused alone (via the femoral vein) or simultaneously with zidovudine (66 micrograms/min/kg) to three near-term pregnant macaques. No significant differences were found between the mean steady-state plasma stavudine concentrations in the dam (Cssd) and fetus (Cssf), the stavudine concentration in the amniotic fluid (Cssa), and the ratios Cssf/Cssd and Cssa/Cssf when stavudine was infused alone or in combination with zidovudine. The data obtained indicate that zidovudine administration does not affect the transfer of stavudine across the placenta in Macaca nemestrina.

Full Text

The Full Text of this article is available as a PDF (211.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Connor E. M., Sperling R. S., Gelber R., Kiselev P., Scott G., O'Sullivan M. J., VanDyke R., Bey M., Shearer W., Jacobson R. L. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1994 Nov 3;331(18):1173–1180. doi: 10.1056/NEJM199411033311801. [DOI] [PubMed] [Google Scholar]
  2. Cretton E. M., Zhou Z., Kidd L. B., McClure H. M., Kaul S., Hitchcock M. J., Sommadossi J. P. In vitro and in vivo disposition and metabolism of 3'-deoxy-2',3'-didehydrothymidine. Antimicrob Agents Chemother. 1993 Sep;37(9):1816–1825. doi: 10.1128/aac.37.9.1816. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Delfraissy J. F., Blanche S., Rouzioux C., Mayaux M. J. Perinatal HIV transmission facts and controversies. Immunodefic Rev. 1992;3(4):305–327. [PubMed] [Google Scholar]
  4. Du D. L., Volpe D. A., Grieshaber C. K., Murphy M. J., Jr In vitro toxicity of 3'-azido-3'-deoxythymidine, carbovir and 2',3'-didehydro-2',3'-dideoxythymidine to human and murine haematopoietic progenitor cells. Br J Haematol. 1992 Apr;80(4):437–445. doi: 10.1111/j.1365-2141.1992.tb04555.x. [DOI] [PubMed] [Google Scholar]
  5. Dudley M. N., Graham K. K., Kaul S., Geletko S., Dunkle L., Browne M., Mayer K. Pharmacokinetics of stavudine in patients with AIDS or AIDS-related complex. J Infect Dis. 1992 Sep;166(3):480–485. doi: 10.1093/infdis/166.3.480. [DOI] [PubMed] [Google Scholar]
  6. Hirsch M. S., D'Aquila R. T. Therapy for human immunodeficiency virus infection. N Engl J Med. 1993 Jun 10;328(23):1686–1695. doi: 10.1056/NEJM199306103282307. [DOI] [PubMed] [Google Scholar]
  7. Ho H. T., Hitchcock M. J. Cellular pharmacology of 2',3'-dideoxy-2',3'-didehydrothymidine, a nucleoside analog active against human immunodeficiency virus. Antimicrob Agents Chemother. 1989 Jun;33(6):844–849. doi: 10.1128/aac.33.6.844. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kaul S., Dandekar K. A. Pharmacokinetics of the anti-human immunodeficiency virus nucleoside analog stavudine in cynomolgus monkeys. Antimicrob Agents Chemother. 1993 May;37(5):1160–1162. doi: 10.1128/aac.37.5.1160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Lopez-Anaya A., Unadkat J. D., Schumann L. A., Smith A. L. Pharmacokinetics of zidovudine (azidothymidine). I. Transplacental transfer. J Acquir Immune Defic Syndr. 1990;3(10):959–964. [PubMed] [Google Scholar]
  10. Lopez-Anaya A., Unadkat J. D., Schumann L. A., Smith A. L. Pharmacokinetics of zidovudine (azidothymidine). III. Effect of pregnancy. J Acquir Immune Defic Syndr. 1991;4(1):64–68. [PubMed] [Google Scholar]
  11. Mansuri M. M., Hitchcock M. J., Buroker R. A., Bregman C. L., Ghazzouli I., Desiderio J. V., Starrett J. E., Sterzycki R. Z., Martin J. C. Comparison of in vitro biological properties and mouse toxicities of three thymidine analogs active against human immunodeficiency virus. Antimicrob Agents Chemother. 1990 Apr;34(4):637–641. doi: 10.1128/aac.34.4.637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Merigan T. C. Treatment of AIDS with combinations of antiretroviral agents. Am J Med. 1991 Apr 10;90(4A):8S–17S. doi: 10.1016/0002-9343(91)90405-m. [DOI] [PubMed] [Google Scholar]
  13. Morton W. R., Knitter G. H., Smith P. M., Susor T. G., Schmitt K. Alternatives to chronic restraint of nonhuman primates. J Am Vet Med Assoc. 1987 Nov 15;191(10):1282–1286. [PubMed] [Google Scholar]
  14. Ochs H. D., Morton W. R., Tsai C. C., Thouless M. E., Zhu Q., Kuller L. D., Wu Y. P., Benveniste R. E. Maternal-fetal transmission of SIV in macaques: disseminated adenovirus infection in an offspring with congenital SIV infection. J Med Primatol. 1991 Jun;20(4):193–200. [PubMed] [Google Scholar]
  15. Odinecs A., Nosbisch C., Keller R. D., Baughman W. L., Unadkat J. D. In vivo maternal-fetal pharmacokinetics of stavudine (2',3'-didehydro-3'-deoxythymidine) in pigtailed macaques (Macaca nemestrina). Antimicrob Agents Chemother. 1996 Jan;40(1):196–202. doi: 10.1128/aac.40.1.196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Pereira C. M., Nosbisch C., Baughman W. L., Unadkat J. D. Effect of zidovudine on transplacental pharmacokinetics of ddI in the pigtailed macaque (Macaca nemestrina). Antimicrob Agents Chemother. 1995 Feb;39(2):343–345. doi: 10.1128/aac.39.2.343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Pereira C. M., Nosbisch C., Winter H. R., Baughman W. L., Unadkat J. D. Transplacental pharmacokinetics of dideoxyinosine in pigtailed macaques. Antimicrob Agents Chemother. 1994 Apr;38(4):781–786. doi: 10.1128/aac.38.4.781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Ravasco R. J., Unadkat J. D., Tsai C. C., Nosbisch C. Pharmacokinetics of dideoxyinosine in pigtailed macaques (Macaca nemestrina) after intravenous and subcutaneous administration. J Acquir Immune Defic Syndr. 1992 Oct;5(10):1016–1018. [PubMed] [Google Scholar]
  19. Russell J. W., Whiterock V. J., Marrero D., Klunk L. J. Disposition in animals of a new anti-HIV agent: 2',3'-didehydro-3'-deoxythymidine. Drug Metab Dispos. 1990 Mar-Apr;18(2):153–157. [PubMed] [Google Scholar]
  20. Schinazi R. F., Boudinot F. D., Doshi K. J., McClure H. M. Pharmacokinetics of 3'-fluoro-3'-deoxythymidine and 3'-deoxy-2',3'-didehydrothymidine in rhesus monkeys. Antimicrob Agents Chemother. 1990 Jun;34(6):1214–1219. doi: 10.1128/aac.34.6.1214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Tuntland T., Ravasco R. J., al-Habet S., Unadkat J. D. Efflux of zidovudine and 2',3'-dideoxyinosine out of the cerebrospinal fluid when administered alone and in combination to Macaca nemestrina. Pharm Res. 1994 Feb;11(2):312–317. doi: 10.1023/a:1018928013044. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES